These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
721 related articles for article (PubMed ID: 8481913)
1. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms. Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913 [TBL] [Abstract][Full Text] [Related]
2. [Serum tumor necrosis factor-alpha levels in non-Hodgkin's lymphoma patients and its relationship to prognosis]. Li D; Li G; Wang B Zhonghua Zhong Liu Za Zhi; 1997 Jul; 19(4):293-6. PubMed ID: 11038763 [TBL] [Abstract][Full Text] [Related]
3. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Othman Eel-D; Hornung D; Salem HT; Khalifa EA; El-Metwally TH; Al-Hendy A Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):240-6. PubMed ID: 17582674 [TBL] [Abstract][Full Text] [Related]
4. Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. Bonnet C; Beguin Y; Fassotte MF; Seidel L; Luyckx F; Fillet G Eur J Haematol; 2007 May; 78(5):399-404. PubMed ID: 17419741 [TBL] [Abstract][Full Text] [Related]
6. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Zhang GJ; Adachi I Anticancer Res; 1999; 19(2B):1427-32. PubMed ID: 10365118 [TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of beta(2)-microglobulin in patients with Hodgkin's lymphoma. Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Karkantaris C; Kokoris SI; Kyrtsonis MC; Tsaftaridis P; Pizzolo G; Pangalis GA Haematologica; 2002 Jul; 87(7):701-8; discussion 708. PubMed ID: 12091120 [TBL] [Abstract][Full Text] [Related]
8. [Measurement of five cytokines in the serum of malignant lymphoma patients]. Zhu H; Wang Y; Han X Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):85-8. PubMed ID: 10921109 [TBL] [Abstract][Full Text] [Related]
9. The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL). Ozdemir F; Aydin F; Yilmaz M; Kavgaci H; Bektas O; Yavuz MN; Yavuz AA J Exp Clin Cancer Res; 2004 Sep; 23(3):485-8. PubMed ID: 15595640 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin's lymphoma. Hentschel N; Krusch M; Kiener PA; Kolb HJ; Salih HR; Schmetzer HM Eur J Haematol; 2006 Aug; 77(2):91-101. PubMed ID: 16800841 [TBL] [Abstract][Full Text] [Related]
11. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma]. Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831 [TBL] [Abstract][Full Text] [Related]
12. Antiphospholipid antibodies: prevalence, clinical significance and correlation to cytokine levels in acute myeloid leukemia and non-Hodgkin's lymphoma. Stasi R; Stipa E; Masi M; Oliva F; Sciarra A; Perrotti A; Zaccari G; Papa G Thromb Haemost; 1993 Oct; 70(4):568-72. PubMed ID: 8115979 [TBL] [Abstract][Full Text] [Related]
13. [Importance of determination of serum beta-2-microglobulin levels in patients with Hodgkin's lymphoma]. Raida L; Papajík T; Hlusí A; Faber E; Urbanová R; Heczko M; Jancíková M; Zapletalová J; Komenda S; Indrák K Vnitr Lek; 2002 Feb; 48(2):91-5. PubMed ID: 11949228 [TBL] [Abstract][Full Text] [Related]
14. Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Voorzanger N; Touitou R; Garcia E; Delecluse HJ; Rousset F; Joab I; Favrot MC; Blay JY Cancer Res; 1996 Dec; 56(23):5499-505. PubMed ID: 8968107 [TBL] [Abstract][Full Text] [Related]
15. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma. Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126 [TBL] [Abstract][Full Text] [Related]
16. Maternal serum levels of interferon-gamma and interleukin-2 soluble receptor-alpha predict the outcome of early IVF pregnancies. Fasouliotis SJ; Spandorfer SD; Witkin SS; Schattman G; Liu HC; Roberts JE; Rosenwaks Z Hum Reprod; 2004 Jun; 19(6):1357-63. PubMed ID: 15105393 [TBL] [Abstract][Full Text] [Related]
17. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity. Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317 [TBL] [Abstract][Full Text] [Related]
18. Effect of granulocyte colony-stimulating factor on IL-12 p40 production during chemotherapy for B-cell lineage non-Hodgkin's lymphoma patients. Toubai T; Tanaka J; Ota S; Fukuhara T; Hashino S; Kondo T; Shono Y; Morioka M; Kawamura T; Masauzi N; Kakinoki Y; Kobayashi H; Kunieda Y; Kasai M; Kurosawa M; Asaka M; Imamura M Eur J Haematol; 2006 Nov; 77(5):403-9. PubMed ID: 16930137 [TBL] [Abstract][Full Text] [Related]
19. Cytokines in pancreatic carcinoma: correlation with phenotypic characteristics and prognosis. Ebrahimi B; Tucker SL; Li D; Abbruzzese JL; Kurzrock R Cancer; 2004 Dec; 101(12):2727-36. PubMed ID: 15526319 [TBL] [Abstract][Full Text] [Related]
20. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma. Bien E; Balcerska A Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]